ロード中...
Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany†
PURPOSE: A prospective, epidemiologic study was conducted to assess whether the 2009 pandemic influenza A(H1N1) vaccination in Germany almost exclusively using an AS03-adjuvanted vaccine (Pandemrix) impacts the risk of Guillain–Barré syndrome (GBS) and its variant Fisher syndrome (FS). METHODS: Pote...
保存先:
| 出版年: | Pharmacoepidemiol Drug Saf |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4282476/ https://ncbi.nlm.nih.gov/pubmed/24817531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3638 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|